Aspira Pathlab & Diagnostics logo

Aspira Pathlab & Diagnostics

ASPIRAPATHLABLTD NSE

Key Fundamentals

MicrocapHealthcare Service ProviderHealthcare Services
Market Cap
₹97.30 Cr
Volatility
Moderate
P/E Ratio
-214.9
EBITDA
₹3.90 Cr
Return on Equity
16.62%
Debt to Equity
0.27
Book Value
₹11.88
EPS
₹0
52W High
₹135.88
52W Low
₹49

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company has reduced debt.
  • Debtor days have improved from 42.1 to 25.3 days.
  • Promoter holding has increased by 28.2% over last quarter.

Weaknesses

6
  • Stock is trading at 8.00 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -2.31% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.0.53 Cr.

Growth Rate

Revenue Growth
64.71% higher than 3Y
Net Income Growth
-174% lower than 3Y
Cash Flow Change
74.29% higher than 3Y
ROE
-163%
ROCE
-186%
EBITDA Margin (Avg.)
-411%

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
2.6
3.32
3.46
3.82
4.64
6.18
5.41
5.78
5.25
8.09
5.12
6.52
6.17
Expenses
2.92
3.68
3.83
3.95
4.29
4.83
4.65
4.73
4.44
5.9
6.33
6.85
5.83
Operating Profit
-0.32
-0.36
-0.37
-0.13
0.35
1.35
0.76
1.05
0.81
2.19
-1.21
-0.33
0.34
OPM %
-12.31%
-10.84%
-10.69%
-3.4%
7.54%
21.84%
14.05%
18.17%
15.43%
27.07%
-23.63%
-5.06%
5.51%
Other Income
0.1
0.14
0.1
0.08
0.09
0.08
0.09
0.13
0.11
0.14
0.13
0.14
0.12
Interest
0.1
0.1
0.09
0.08
0.08
0.08
0.09
0.09
0.09
0.1
0.1
0.1
0.09
Depreciation
0.39
0.39
0.38
0.38
0.38
0.36
0.39
0.37
0.37
0.4
0.38
0.4
0.41
PBT
-0.71
-0.71
-0.74
-0.51
-0.02
0.99
0.37
0.72
0.46
1.83
-1.56
-0.69
-0.04
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
-0.72
-0.71
-0.74
-0.5
-0.02
0.99
0.38
0.72
0.47
1.84
-1.56
-0.69
-0.04
EPS in Rs
-0.7
-0.69
-0.72
-0.49
-0.02
0.96
0.37
0.7
0.46
1.79
-1.52
-0.67
-0.04
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0.76
4.36
7.64
8.42
15.21
19.54
14.46
13.2
22
24.98
25.9
Expenses
0.14
0.23
3.34
8.24
10.88
10.25
11.69
13.16
12.86
14.38
18.44
23.52
24.91
Operating Profit
-0.14
-0.23
-2.58
-3.88
-3.24
-1.83
3.52
6.38
1.6
-1.18
3.56
1.46
0.99
OPM %
—
—
-339.47%
-88.99%
-42.41%
-21.73%
23.14%
32.65%
11.07%
-8.94%
16.18%
5.84%
3.82%
Other Income
0.21
0.32
0.31
0.22
0.25
0.29
0.2
0.09
0.32
0.42
0.36
0.52
0.53
Interest
0
0.05
0.26
0.8
0.96
1.01
0.89
0.37
0.42
0.37
0.35
0.39
0.39
Depreciation
0
0
0.2
1.12
1.23
1.66
1.44
1.64
1.59
1.54
1.49
1.54
1.59
PBT
0.07
0.04
-2.73
-5.58
-5.18
-4.21
1.39
4.46
-0.09
-2.67
2.08
0.05
-0.46
Tax %
57.14%
25%
0%
0%
0%
0.71%
0%
0%
0%
0%
0%
0%
—
Net Profit
0.02
0.03
-2.72
-5.58
-5.18
-4.24
1.38
4.46
-0.09
-2.67
2.07
0.05
-0.45
EPS in Rs
0.09
0.13
-5.24
-10.75
-6.32
-4.56
1.34
4.33
-0.09
-2.59
2.01
0.05
-0.44
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.25
2.25
5.19
5.19
8.19
9.29
10.29
10.29
10.29
10.29
10.29
10.29
Reserves
1.36
1.39
0.72
-4.86
-7.93
-10.42
-6.91
-2.43
-2.47
-5.08
-3.01
1.94
Borrowings
0
2.62
7.29
11.36
12.52
13.8
7.01
8.85
8.24
7.71
8.13
3.32
Other Liabilities
0.21
0.03
1.66
0.84
2.02
1.67
1.39
1.42
1.28
1.79
2.11
2.96
Total Liabilities
3.82
6.29
14.86
12.53
14.8
14.34
11.78
18.13
17.34
14.71
17.52
18.51
Fixed Assets
0
0.04
7.79
7.91
8.9
8.7
7.75
9.57
8.01
6.79
6.53
7.2
CWIP
0
0
0.25
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0.13
0
Other Assets
3.82
6.25
6.82
4.62
5.9
5.64
4.03
8.56
9.33
7.92
10.86
11.31
Total Assets
3.82
6.29
14.86
12.53
14.8
14.34
11.78
18.13
17.34
14.71
17.52
18.51
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
-0.37
-1.29
-4.81
-3.39
-1.87
5.67
2.03
-0.01
1.05
1.88
1.45
Investing
—
-0.02
-10.14
-0.77
-1.97
0.24
-0.09
-0.51
0.16
0.14
0.07
-0.8
Financing
—
2.64
8.91
6.52
3.35
1.27
-2.17
-1.35
-0.94
-0.95
-0.99
-1.14
Net Cash Flow
—
2.25
-2.52
0.94
-2
-0.35
3.41
0.17
-0.79
0.24
0.95
-0.49
Free Cash Flow
—
-0.41
-8.41
-5.81
-3.9
-1.92
5.37
1.42
-0.15
0.79
1.71
0.75
CFO/OP
—
139
50
124
105
101
161
32
-1
-89
53
99
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
43.22
29.3
38.22
26.01
40.8
83.87
59.07
61.94
38.99
25.28
Inventory Days
—
—
313
104
45.22
51.36
51.35
46.5
58.4
62.69
50.31
56.53
Days Payable
—
—
730
64.58
46.84
73.37
91.6
70.91
51.1
102
73
92.06
Cash Conversion Cycle
—
—
-374
68.61
36.6
4
0.55
59.46
66.37
22.93
16.3
-10.25
Working Capital Days
—
—
-2,200
-5.86
-96.03
-127
16.32
69.3
48.72
25.16
14.1
-4.24
ROCE %
—
1.82%
-25.39%
-38.41%
-34.49%
-25.15%
19.77%
35.65%
2.01%
-15.87%
17.37%
2.84%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Aspira Pathlab & Diagnostics insights

59 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

Promot.46.58%Others12.72%Public40.70%As ofJun 2026

Documents

Frequently Asked Questions about Aspira Pathlab & Diagnostics

What does Aspira Pathlab & Diagnostics Ltd do?
Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services[1]
Where is Aspira Pathlab & Diagnostics Ltd (540788) listed?
Aspira Pathlab & Diagnostics Ltd trades as ASPIRAPATHLABLTD on the NSE and under code 540788 on the BSE.
Which sector does Aspira Pathlab & Diagnostics Ltd belong to?
Aspira Pathlab & Diagnostics Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd has a market capitalisation of ₹97.3 Cr, which places it in the Small Cap band.
What is the PE ratio of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd trades at a PE ratio of -214.90, on earnings per share of ₹0, against a book value of ₹11.88 per share.
What is the 52-week high and low of Aspira Pathlab & Diagnostics Ltd?
Over the last 52 weeks Aspira Pathlab & Diagnostics Ltd has traded between ₹49 and ₹135.88.
What is the Return on Equity (ROE) of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd reported a return on equity of 16.62%. Its debt-to-equity ratio is 0.27.

Company Information

Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services[1]

Website aspiradiagnostics.com
CEO Dr. Pankaj Jashwant Shah
Employees 141
Listed 2018-02-28
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540788.md for Aspira Pathlab & Diagnostics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List